Impacts of an Advanced Practice Physiotherapy Model of Care for Adults With a Peripheral Musculoskeletal Disorders Referred to an Orthropaedic Outpatient Clinic

Sponsor
Ciusss de L'Est de l'Île de Montréal (Other)
Overall Status
Recruiting
CT.gov ID
NCT05714332
Collaborator
CIUSSS du Nord-de-l'Île-de-Montréal (Other)
152
1
8.5
17.8

Study Details

Study Description

Brief Summary

The goal of this prospective observational study is to evaluate advanced practice physiotherapy and orthopedic surgeon care and clinical outcomes for new patients with a peripheral musculoskeletal disorders consulting at the orthopedic outpatient clinic of the Hôpital Jean-Talon.

The main questions it aims to answer are: 1. To describe the models of care at the Hôpital Jean-Talon orthopedic outpatient clinic; 2. To assess change in pain, disability, quality of life and pain catastrophizing at 6, 12 and 26 weeks after the initial evaluation; 3. To assess interprofessional collaboration between the advanced practice physiotherapists and orthopedic surgeons; 4. To assess patient satisfaction with care; 5. To assess waiting time before an initial consultation.

Researchers will compare patients cared in the advanced practice physiotherapy and orthopedic surgeon group and the orthopedic surgeon only group.

Condition or Disease Intervention/Treatment Phase
  • Other: Advanced practice physiotherapy and orthopedic surgeon management
  • Other: Orthopedic surgeon management

Study Design

Study Type:
Observational
Anticipated Enrollment :
152 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impacts of an Advanced Practice Physiotherapy Model of Care for Adults With a Peripheral Musculoskeletal Disorders Referred to an Orthropaedic Outpatient Clinic: a Prospective Observational Study
Actual Study Start Date :
Nov 14, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Advanced practice physiotherapy and orthopedic surgeon group

Patients cared by both an advanced practice physiotherapist and an orthopedic surgeon.

Other: Advanced practice physiotherapy and orthopedic surgeon management
Management of their musculoskeletal condition by an advanced practice physiotherapist and an orthopedic surgeon.

Orthopedic surgeon only group

Patients cared only by an orthopedic surgeon.

Other: Orthopedic surgeon management
Management of their musculoskeletal condition by an orthopedic surgeon.

Outcome Measures

Primary Outcome Measures

  1. Brief pain inventory severity [6 weeks (change from baseline)]

    Pain questionnaire (0-10; higher score=worse)

  2. Brief pain inventory severity [12 weeks (change from baseline)]

    Pain questionnaire (0-10; higher score=worse)

  3. Brief pain inventory severity [26 weeks (change from baseline)]

    Pain questionnaire (0-10; higher score=worse)

  4. Brief pain inventory inventory [6 weeks (change from baseline)]

    Pain interference (disability) questionnaire (0-10; higher score=worse)

  5. Brief pain inventory inventory [12 weeks (change from baseline)]

    Pain interference (disability) questionnaire (0-10; higher score=worse)

  6. Brief pain inventory inventory [26 weeks (change from baseline)]

    Pain interference (disability) questionnaire (0-10; higher score=worse)

Secondary Outcome Measures

  1. Shortened Disability of the Arm, Shoulder and Hand (QuickDASH) [6 weeks (change from baseline)]

    Disability questionnaire for upper extremity disorders (0-100; higher=worse)

  2. Shortened Disability of the Arm, Shoulder and Hand (QuickDASH) [12 weeks (change from baseline)]

    Disability questionnaire for upper extremity disorders (0-100; higher=worse)

  3. Shortened Disability of the Arm, Shoulder and Hand (QuickDASH) [26 weeks (change from baseline)]

    Disability questionnaire for upper extremity disorders (0-100; higher=worse)

  4. Hip disability and Osteoarthritis Outcomes Score (HOOS) [6 weeks (change from baseline)]

    Disability questionnaire for hip disorders (0-100; higher=better)

  5. Hip disability and Osteoarthritis Outcomes Score (HOOS) [12 weeks (change from baseline)]

    Disability questionnaire for hip disorders (0-100; higher=better)

  6. Hip disability and Osteoarthritis Outcomes Score (HOOS) [26 weeks (change from baseline)]

    Disability questionnaire for hip disorders (0-100; higher=better)

  7. Knee injury and Osteoarthritis Outcomes Score (KOOS) [6 weeks (change from baseline)]

    Disability questionnaire for knee disorders (0-100; higher=better)

  8. Knee injury and Osteoarthritis Outcomes Score (KOOS) [12 weeks (change from baseline)]

    Disability questionnaire for knee disorders (0-100; higher=better)

  9. Knee injury and Osteoarthritis Outcomes Score (KOOS) [26 weeks (change from baseline)]

    Disability questionnaire for knee disorders (0-100; higher=better)

  10. Foot and Ankle Ability Measure (FAAM) [6 weeks (change from baseline)]

    Disability questionnaire for ankle/foot disorders (0-100; higher=better)

  11. Foot and Ankle Ability Measure (FAAM) [12 weeks (change from baseline)]

    Disability questionnaire for ankle/foot disorders (0-100; higher=better)

  12. Foot and Ankle Ability Measure (FAAM) [26 weeks (change from baseline)]

    Disability questionnaire for ankle/foot disorders (0-100; higher=better)

  13. EQ-5D-5L [6 weeks (change from baseline)]

    Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)

  14. EQ-5D-5L [12 weeks (change from baseline)]

    Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)

  15. EQ-5D-5L [26 weeks (change from baseline)]

    Health-related quality of life questionnaire (to be converted in QALYs 0-1; higher=better)

  16. EQ-5D-VAS [6 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-100; higher=better)

  17. EQ-5D-VAS [12 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-100; higher=better)

  18. EQ-5D-VAS [26 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-100; higher=better)

  19. Pain Catastrophizing Scale (PCS) [6 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-50; higher=worse)

  20. Pain Catastrophizing Scale (PCS) [12 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-50; higher=worse)

  21. Pain Catastrophizing Scale (PCS) [26 weeks (change from baseline)]

    Health-related quality of life questionnaire (0-50; higher=worse)

  22. Patient perceptions of team effectiveness (Patient-PTE) [0 week (post initial consultation)]

    Perceptions of team effectiveness questionnaire (24-144; higher=better)

  23. modified validated version of the 9-item visit-specific satisfaction questionnaire (VSQ-9) [0 week (post initial consultation)]

    Patient satisfaction questionnaire (0-100; higher=better)

  24. Modified MedRisk [12 weeks]

    Patient satisfaction questionnaire (0-100; higher=better)

  25. Modified MedRisk [26 weeks]

    Patient satisfaction questionnaire (0-100; higher=better)

  26. Provider perceptions of team effectiveness (Prodiver-PTE) [Through study completion (once)]

    Perceptions of team effectiveness questionnaire (26-156; higher=better)

  27. Waiting time [Pre-intervention]

    Waiting time (time in days and minutes)

  28. Adverse events [12 weeks]

    Rate of adverse events

  29. Adverse events [26 weeks]

    Rate of adverse events

  30. Treatment and compliance [6 weeks]

    Treatment received and % of treatment compliance

  31. Treatment and compliance [12 weeks]

    Treatment received and % of treatment compliance

  32. Treatment and compliance [26 weeks]

    Treatment received and % of treatment compliance

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Adults with peripheral musculoskeletal disorders

  • New consultation at the Hôpital Jean-Talon orthopedic outpatient clinic

  • Legally able to consent

  • Understand and speak French or English

  • Beneficiaries of the provincial universal health insurance coverage (RAMQ)

Exclusion Criteria:
  • Patients directly referred from the emergency department (not considered as patients referred to the outpatient clinic).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre de recherche de l'Hôpital Maisonneuve-Rosemont Montréal Quebec Canada H1T 2M4

Sponsors and Collaborators

  • Ciusss de L'Est de l'Île de Montréal
  • CIUSSS du Nord-de-l'Île-de-Montréal

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ciusss de L'Est de l'Île de Montréal
ClinicalTrials.gov Identifier:
NCT05714332
Other Study ID Numbers:
  • v3
First Posted:
Feb 6, 2023
Last Update Posted:
Feb 6, 2023
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ciusss de L'Est de l'Île de Montréal
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 6, 2023